UBS/CALL/GALENICA/80.002/0.05/20.06.25 Stock

Warrant

HGALDU

CH1312126217

Market Closed - Swiss Exchange 11:20:00 2024-07-11 am EDT
0.18 CHF +5.88% Intraday chart for UBS/CALL/GALENICA/80.002/0.05/20.06.25
Current month+28.57%
1 month+28.57%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 0.18 +5.88%
24-07-10 0.17 +6.25%

Delayed Quote Swiss Exchange

Last update July 11, 2024 at 11:20 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying GALENICA AG
Issuer UBS
HGALDU
ISINCH1312126217
Date issued 2023-12-18
Strike 80 CHF
Maturity 2025-06-20 (342 Days)
Parity 20 : 1
Emission price 0.16 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 0.24 CHF
Lowest since issue 0.09 CHF
Spread 0.01 CHF
Spread %5.26%

Company Profile

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Sector
-
More about the company

Ratings for Galenica AG

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Galenica AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
75.65 CHF
Average target price
77 CHF
Spread / Average Target
+1.78%
Consensus
  1. Stock Market
  2. Warrants
  3. HGALDU Warrant